Ambulance heat may not spoil life-saving bleeding treatments

NCT ID NCT07646964

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether two blood-clotting products — human fibrinogen and freeze-dried plasma — remain stable when stored in an ambulance under everyday conditions, including summer heat. Researchers in Graz, Austria, will compare samples stored in the ambulance with ones kept under ideal conditions over four months. The goal is to see if current storage practices in emergency vehicles are good enough to keep these products effective for treating severe bleeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

human fibrinogen (Fibryga) and lyophilized human plasma (Octaplas LG AB)

What this could lead to

If these products remain stable, it could confirm that current ambulance storage practices are safe for emergency bleeding treatments.

What could go wrong

This is a very small observational study (only 2 samples) in one city, so results may not apply to other settings or climates.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXANGUINATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••